Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Cancer Biomarkers and Targets in Digestive Organs
| Cancer Biomarkers and Targets in Digestive Organs |
| Autore | Lee Nikki |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
| Descrizione fisica | 1 electronic resource (146 p.) |
| Soggetto non controllato |
liver graft injury
HFE neurokinin chemotherapy intestinal tumors therapeutic targets biliary tract carcinoma hepatocellular carcinoma clinical trial cell adhesion molecules colorectal cancer biomarkers phenotypic mosaics gastrointestinal oncology Asian Cancer Research Group (ACRG) biomarker psychosocial support precision therapy pancreatic carcinoma precision medicine Liver transplantation predictive biomarkers CD274 cholecystokinin The Cancer Genome Atlas (TCGA) gastrin pembrolizumab immunotherapy gastrin-releasing peptide stereotactic body radiation therapy immunohistochemistry gastric carcinoma liver transplant CAM invasion assay intragraft gene expression profiles molecular profiling targeted therapy neurotensin intestinal disorder ramucirumab next-generation sequencing colorectal carcinoma tumor progenitor circulating tumor cells gastrointestinal malignancies bombesin trastuzumab somatostatin zebrafish G protein-coupled receptors |
| ISBN | 3-03921-464-0 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910367564003321 |
Lee Nikki
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Immunophenotyping in Autoimmune Diseases and Cancer
| Immunophenotyping in Autoimmune Diseases and Cancer |
| Autore | Szebeni Gábor J |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 electronic resource (170 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
CD8+CD28− T cells
cancer immunology glioblastoma immunotherapy malignant glioma cancer accidental cell death oncosis DDR parthanatos flow cytometry systemic lupus erythematosus T cells glycosylation sialylation lectin binding glycosylation enzymes galectin 1 choriocarcinoma hydatidiform mole galectin gestational trophoblastic disease placental-specific gene systems biology trophoblast differentiation B cells non-switched B cells systemic sclerosis dcSSc TLR CD180 RP105 CpG IL-6 IL-10 natural autoantibodies IgM citrate synthase DNA topoisomerase I unfolded protein response Inositol-requiring enzyme 1 (IRE1) PKR-like endoplasmic reticulum kinase (PERK) Glucose-regulated protein 78 (GRP78) Activating transcription factor 6 (ATF6) immune cells T cell macrophage tumor microenvironment single cell mass cytometry metastatic breast cancer myeloid-derived suppressor cells immunophenotyping breast cancer trastuzumab chimeric antigen receptor cell therapy neuroendocrine neoplasia neuroendocrine tumor neuroendocrine carcinoma immunohistochemistry syntaxin 1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557289203321 |
|
Szebeni Gábor J
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Molecular Pathways in Cancers
| Molecular Pathways in Cancers |
| Autore | Cristóbal Ion |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 electronic resource (284 p.) |
| Soggetto topico |
Medicine
Oncology |
| Soggetto non controllato |
actin cytoskeletal reorganization
breast cancer CD99 agonist EGFR dimerization endocytosis FAK dephosphorylation PTPN12 Rac1 RhoA tripeptide OMD PRELP tumor suppression gene bladder cancer initiation tight junction partial EMT tousled-like kinase (TLK) NIMA-related kinase 1 (NEK1) yes-associated protein 1 (YAP1) thioridazine (THD) MS-determined phosphopeptides human immunodeficiency virus type 1 epithelial cells carcinogenicity oxidative stress reactive oxygen species gp120 Tat Nef matrix protein p17 reverse transcriptase mitochondria metastasis OXPHOS cancer Warburg effect cancer therapeutics myeloproliferative neoplasms signaling pathways JAK2 CALR MPL TPOR DUSP1 MAPK Snail prostate cancer migration and invasion patient survival biomarkers pBRD4 SET PP2A prognosis triple negative breast cancer resistance anti-receptor therapy trastuzumab PI3K mTOR TAK-228 epigenetic methylation acetylation non-coding RNA small-cell lung cancer triple-negative breast cancer pancreatic ductal adenocarcinoma glioblastoma metastatic melanoma advanced ovarian cancer hepatocellular carcinoma immune evasion immunotherapy immune checkpoint inhibitors oncogenic signaling pathway molecular targeted agents genome epigenome tumor immune microenvironment ovarian cancer adaptive immunity innate immunity complement system cancer immunology tumor microenvironment splicing pathway luminal breast cancer BET inhibitors |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910566473703321 |
|
Cristóbal Ion
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Treatment Strategies and Survival Outcomes in Breast Cancer
| Treatment Strategies and Survival Outcomes in Breast Cancer |
| Autore | Cheung Kwok-Leung |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 electronic resource (264 p.) |
| Soggetto non controllato |
relative survival
young women cancer treatment fulvestrant lapatinib tumor biology antihormone therapy mastectomy aromatase inhibitors chemotherapy serum biomarker cyclin E anthracycline resistance zero-inflated Poisson regression model lymph-node ratio CHEK2 comparative effectiveness breast-conserving therapy taxane sensitivity liquid biopsy HER2 c-erbB2 colorectal cancer infiltrating breast cancer survival exercise characteristics lactate dehydrogenase biomarker breast cancer survivors BRCA disease-free survival PIK3CA metastatic breast cancer cell-free DNA invasive breast cancer radiotherapy Metformin social well-being gene expression contralateral breast cancer basal-like breast cancer LMK-235 Src kinase HER2/neu LKB1 Older women LDH mutation carriers stage IV mammography screening NCDB cMet SEER pertuzumab physical function outcome ribociclib older patients geriatric oncology metastatic overdiagnosis next-generation sequencing abemaciclib Endocrine therapy monitoring metastatic breast cancer breast cancer circulating tumor cells Breast Cancer PALB2 histone deacetylase prognosis physical activity trastuzumab ductal carcinoma in situ contralateral prophylactic mastectomy ERCC1 family history T-DM1 ATM advanced breast cancer incidence palbociclib HDAC5 inhibitors APOBEC3B |
| ISBN | 3-03928-759-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910404084403321 |
|
Cheung Kwok-Leung
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||